Balance Sheet Insmed Incorporated

Equities

INSM

US4576693075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 06:00:00 16/04/26 am AEST			5-day change	1st Jan Change
146.74 ^USD	-4.34%		-8.39%	-15.69%

15/04	Insmed Sees Favorable Physician Feedback on Brinsupri, RBC Capital Markets Says	MT
14/04	RBC Raises Price Target on Insmed to $216 From $212, Keeps Outperform Rating	MT

4a9ffc3b925ee756c5f6f29233593.3DTfS-8n-EUu8K6zCbgN_Oh1bsCfpsW-KnN87VyHV7c.5Vm3GdpJsitYofnERf9puKc9KPiy4fDndSMEvSnyOditd7V7wnKqch-YxQ

Published financial data: INSMED INCORPORATED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	188M	245M	305M	364M	606M
Total Revenues	188M	245M	305M	364M	606M
Cost of Goods Sold, Total	44.15M	55.13M	65.57M	85.74M	123M
Gross Profit	144M	190M	240M	278M	483M
Selling General & Admin Expenses, Total	234M	266M	345M	461M	701M
R&D Expenses	273M	398M	571M	598M	771M
Amortization of Goodwill and Intangible Assets - (IS)	5.05M	5.05M	5.05M	5.05M	6M
Other Operating Expenses, Total	511M	668M	921M	1.06B	1.48B
Operating Income	-367M	-478M	-681M	-787M	-995M
Interest Expense, Total	-40.47M	-27.97M	-81.37M	-85.15M	-83.8M
Interest And Investment Income	174K	11.08M	42.13M	53.31M	60.66M
Net Interest Expenses	-40.3M	-16.89M	-39.24M	-31.84M	-23.14M
Other Non Operating Income (Expenses)	-3.33M	-5.94M	1.86M	29K	-1.84M
EBT, Excl. Unusual Items	-411M	-501M	-718M	-818M	-1.02B
Merger & Related Restructuring Charges	-600K	-	-	-	-
Other Unusual Items	-25.02M	20.8M	-28.7M	-91.68M	-252M
EBT, Incl. Unusual Items	-436M	-480M	-747M	-910M	-1.27B
Income Tax Expense	-1.76M	1.38M	2.56M	3.71M	5.03M
Earnings From Continuing Operations	-435M	-482M	-750M	-914M	-1.28B
Net Income to Company	-435M	-482M	-750M	-914M	-1.28B
Net Income - (IS)	-435M	-482M	-750M	-914M	-1.28B
Net Income to Common Incl Extra Items	-435M	-482M	-750M	-914M	-1.28B
Net Income to Common Excl. Extra Items	-435M	-482M	-750M	-914M	-1.28B
Per Share Items
Net EPS - Basic	-3.88	-3.91	-5.34	-5.57	-6.42
Basic EPS - Continuing Operations	-3.88	-3.91	-5.34	-5.57	-6.42
Basic Weighted Average Shares Outstanding	112M	123M	140M	164M	199M
Net EPS - Diluted	-3.88	-3.91	-5.34	-5.57	-6.42
Diluted EPS - Continuing Operations	-3.88	-3.91	-5.34	-5.57	-6.42
Diluted Weighted Average Shares Outstanding	112M	123M	140M	164M	199M
Normalized Basic EPS	-2.29	-2.54	-3.2	-3.12	-3.2
Normalized Diluted EPS	-2.29	-2.54	-3.2	-3.12	-3.2
Supplemental Items
EBITDA	-357M	-471M	-672M	-778M	-980M
EBITA	-367M	-478M	-681M	-786M	-994M
EBIT	-367M	-478M	-681M	-787M	-995M
EBITDAR	-338M	-447M	-648M	-741M	-945M
Effective Tax Rate - (Ratio)	0.4	-0.29	-0.34	-0.41	-0.4
Current Domestic Taxes	104K	269K	378K	356K	577K
Current Foreign Taxes	1.58M	1.34M	2.23M	3.38M	4.48M
Total Current Taxes	1.69M	1.61M	2.61M	3.74M	5.05M
Deferred Domestic Taxes	-3.45M	-231K	-54K	-29K	-27K
Total Deferred Taxes	-3.45M	-231K	-54K	-29K	-27K
Normalized Net Income	-257M	-313M	-449M	-511M	-637M
Interest on Long-Term Debt	40.47M	26.45M	81.69M	84.91M	83.8M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	278M	402M	576M	603M	776M
Net Rental Expense, Total	19.17M	24.17M	24.53M	36.23M	35.64M
Imputed Operating Lease Interest Expense	12.2M	5.58M	11.9M	18.5M	23.2M
Imputed Operating Lease Depreciation	6.96M	18.59M	12.64M	17.74M	12.44M
Stock-Based Comp., R&D Exp. (Total)	17.81M	26.38M	35.88M	47.67M	70.05M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	28.21M	31.31M	38.9M	49.16M	82.66M
Stock-Based Comp., Other (Total)	1.3M	1.3M	-	-	-
Total Stock-Based Compensation	47.32M	58.99M	74.78M	96.84M	153M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	717M	1.07B	482M	555M	510M
Short Term Investments	-	74.24M	298M	879M	920M
Total Cash And Short Term Investments	717M	1.15B	780M	1.43B	1.43B
Accounts Receivable, Total	24.35M	29.71M	41.19M	52.01M	141M
Total Receivables	24.35M	29.71M	41.19M	52.01M	141M
Inventory	67.01M	69.92M	83.25M	98.58M	132M
Prepaid Expenses	28.9M	25.47M	24.18M	37.24M	91.24M
Total Current Assets	837M	1.27B	929M	1.62B	1.79B
Gross Property Plant And Equipment	133M	142M	149M	166M	200M
Accumulated Depreciation	-37.06M	-39.44M	-44.63M	-50.31M	-60.76M
Net Property Plant And Equipment	95.52M	102M	104M	116M	139M
Long-term Investments	50.04M	-	-	-	-
Goodwill	136M	136M	136M	136M	136M
Other Intangibles, Total	31.37M	31.17M	30.97M	30.76M	74.61M
Deferred Charges Long-Term	42.44M	37.59M	32.74M	27.89M	23.04M
Other Long-Term Assets, Total	50.99M	76.1M	96.57M	93.23M	97.38M
Total Assets	1.24B	1.66B	1.33B	2.03B	2.26B
Liabilities
Accounts Payable, Total	35.78M	50.46M	65.39M	73.03M	79.91M
Accrued Expenses, Total	83.81M	108M	128M	181M	303M
Current Portion of Leases	10.14M	8.13M	10.64M	12.32M	12.81M
Other Current Liabilities	5.43M	23.64M	21.38M	30.69M	72.8M
Total Current Liabilities	135M	190M	226M	298M	469M
Long-Term Debt	567M	1.27B	1.31B	1.26B	704M
Long-Term Leases	35.54M	44.49M	38.04M	33.18M	32.89M
Other Non Current Liabilities	95.74M	60.49M	87.74M	145M	320M
Total Liabilities	833M	1.57B	1.66B	1.74B	1.53B
Common Stock, Total	1.19M	1.36M	1.48M	1.79M	2.14M
Additional Paid In Capital	2.67B	2.78B	3.11B	4.65B	6.37B
Retained Earnings	-2.27B	-2.7B	-3.45B	-4.36B	-5.64B
Comprehensive Income and Other	968K	756K	-745K	-2.29M	1.46M
Total Common Equity	410M	87.95M	-332M	285M	739M
Total Equity	410M	87.95M	-332M	285M	739M
Total Liabilities And Equity	1.24B	1.66B	1.33B	2.03B	2.26B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	119M	136M	148M	181M	216M
ECS Total Common Shares Outstanding	119M	136M	148M	179M	214M
Book Value / Share	3.46	0.65	-2.24	1.59	3.45
Tangible Book Value	243M	-79.33M	-499M	119M	528M
Tangible Book Value Per Share	2.05	-0.58	-3.37	0.66	2.47
Total Debt	612M	1.33B	1.36B	1.31B	750M
Net Debt	-155M	178M	579M	-124M	-681M
Debt Equivalent Oper. Leases	153M	193M	196M	290M	285M
Account Code - Inventory Valuation	3	3	5	5	5
Inventories - Raw Materials, Total	29.54M	27.24M	24.56M	19.68M	30.62M
Inventories - Work In Process, Total	18.53M	22.46M	33.48M	39.93M	41.35M
Inventories - Finished Goods, Total	18.94M	20.22M	25.21M	38.96M	60.1M
Land - (BS)	-	-	-	-	1.96M
Buildings, Total	-	-	-	-	10.44M
Machinery, Total	26.16M	29.35M	36.51M	41.17M	55.49M
Full Time Employees	613	736	912	1.27K	1.66K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-435M	-482M	-750M	-914M	-1.28B
Depreciation & Amortization - CF	10.21M	7.24M	8.24M	8.67M	13.16M
Amortization of Goodwill and Intangible Assets - (CF)	202K	202K	202K	202K	1.15M
Depreciation & Amortization, Total	10.41M	7.44M	8.44M	8.88M	14.31M
Amortization of Deferred Charges, Total - (CF)	35.89M	8.84M	12.17M	11.73M	11.07M
(Gain) Loss on Sale of Investments - (CF)	-	1.53M	-9.7M	-18.92M	-38.35M
Stock-Based Compensation (CF)	46.02M	57.69M	74.78M	96.84M	153M
Other Operating Activities, Total	37.61M	-974K	167M	135M	282M
Change In Accounts Receivable	-8.12M	-6.42M	-11.96M	-12.93M	-88.31M
Change In Inventories	-17.46M	-1.71M	-13.61M	-17.04M	-31.52M
Change In Accounts Payable	-7.58M	50.01M	15.16M	44.59M	100M
Change in Other Net Operating Assets	-25.43M	-35.3M	-28.8M	-17.79M	-60.55M
Cash from Operations	-363M	-400M	-536M	-684M	-935M
Capital Expenditure	-7.29M	-9.88M	-13.29M	-21.92M	-32.56M
Cash Acquisitions	-6.7M	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-50.29M	-24.71M	-214M	-561M	-2.01M
Other Investing Activities, Total	-	-	3.42M	-	-30M
Cash from Investing	-64.28M	-34.58M	-224M	-583M	-64.58M
Long-Term Debt Issued, Total	575M	500M	-	150M	-
Total Debt Issued	575M	500M	-	150M	-
Long-Term Debt Repaid, Total	-225M	-	-1.22M	-2.61M	-4.93M
Total Debt Repaid	-225M	-	-1.22M	-2.61M	-4.93M
Issuance of Common Stock	292M	312M	171M	1.2B	959M
Other Financing Activities, Total	-29.38M	-18.38M	-1.22M	-3.74M	-
Cash from Financing	613M	793M	168M	1.34B	954M
Foreign Exchange Rate Adjustments	-933K	-996K	-250K	-1.31M	931K
Net Change in Cash	184M	357M	-592M	72.66M	-44.58M
Supplemental Items
Cash Interest Paid	10.89M	10.16M	35.79M	40.57M	55.35M
Cash Income Tax Paid (Refund)	1.56M	1.72M	1.96M	2.5M	4.14M
Levered Free Cash Flow	-180M	-199M	-385M	-418M	-534M
Unlevered Free Cash Flow	-186M	-185M	-341M	-372M	-488M
Change In Net Working Capital	11.34M	-52.24M	-9.36M	-31M	5.48M
Net Debt Issued / Repaid	350M	500M	-1.22M	147M	-4.93M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-22.5	-20.61	-28.5	-29.31	-28.99
Return on Total Capital	-26.94	-24.53	-34.87	-37.49	-40.32
Return On Equity %	-126.66	-193.22	614.47	3.93K	-249.28
Return on Common Equity	-126.66	-193.22	614.47	3.93K	-249.28
Margin Analysis
Gross Profit Margin %	76.57	77.53	78.52	76.43	79.73
SG&A Margin	123.99	108.32	112.87	126.78	115.62
EBITDA Margin %	-189.3	-191.84	-220.34	-213.82	-161.68
EBITA Margin %	-194.71	-194.79	-223.04	-216.21	-163.85
EBIT Margin %	-194.82	-194.87	-223.1	-216.26	-164.04
Income From Continuing Operations Margin %	-230.63	-196.26	-245.59	-251.24	-210.54
Net Income Margin %	-230.63	-196.26	-245.59	-251.24	-210.54
Net Avail. For Common Margin %	-230.63	-196.26	-245.59	-251.24	-210.54
Normalized Net Income Margin	-136.23	-127.61	-147.1	-140.63	-105.1
Levered Free Cash Flow Margin	-95.4	-80.97	-126.14	-115.01	-88.07
Unlevered Free Cash Flow Margin	-98.44	-75.48	-111.87	-102.27	-80.46
Asset Turnover
Asset Turnover	0.18	0.17	0.2	0.22	0.28
Fixed Assets Turnover	1.96	2.48	2.96	3.31	4.76
Receivables Turnover (Average Receivables)	9.21	9.08	8.61	7.8	6.29
Inventory Turnover (Average Inventory)	0.76	0.81	0.86	0.94	1.07
Short Term Liquidity
Current Ratio	6.19	6.69	4.12	5.45	3.83
Quick Ratio	5.48	6.19	3.64	4.99	3.35
Operating Cash Flow to Current Liabilities	-2.69	-2.1	-2.38	-2.3	-1.99
Days Sales Outstanding (Average Receivables)	39.62	40.21	42.4	46.89	58.04
Days Outstanding Inventory (Average Inventory)	481.96	453.32	426.3	388.07	342.39
Average Days Payable Outstanding	233.09	271.19	267.98	250.63	178.43
Cash Conversion Cycle (Average Days)	288.49	222.34	200.71	184.33	222
Long Term Solvency
Total Debt/Equity	149.16	1.51K	-409.44	459.02	101.43
Total Debt / Total Capital	59.87	93.78	132.32	82.11	50.35
LT Debt/Equity	146.69	1.5K	-406.23	454.7	99.69
Long-Term Debt / Total Capital	58.87	93.2	131.28	81.34	49.49
Total Liabilities / Total Assets	66.99	94.69	124.96	85.91	67.37
EBIT / Interest Expense	-9.07	-17.09	-8.37	-9.24	-11.87
EBITDA / Interest Expense	-8.34	-15.96	-7.96	-8.71	-11.28
(EBITDA - Capex) / Interest Expense	-8.52	-16.32	-8.13	-8.97	-11.66
Total Debt / EBITDA	-1.81	-2.97	-2.1	-1.77	-0.79
Net Debt / EBITDA	0.46	-0.4	-0.89	0.17	0.72
Total Debt / (EBITDA - Capex)	-1.78	-2.91	-2.06	-1.72	-0.77
Net Debt / (EBITDA - Capex)	0.45	-0.39	-0.87	0.16	0.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.63	30.19	24.39	19.17	66.73
Gross Profit, 1 Yr. Growth %	15.87	31.82	25.97	16	73.94
EBITDA, 1 Yr. Growth %	39.98	31.94	42.87	15.64	26.07
EBITA, 1 Yr. Growth %	38.43	30.24	42.44	15.52	26.36
EBIT, 1 Yr. Growth %	38.43	30.22	42.42	15.51	26.47
Earnings From Cont. Operations, 1 Yr. Growth %	47.8	10.79	55.66	21.91	39.73
Net Income, 1 Yr. Growth %	47.8	10.79	55.66	21.91	39.73
Normalized Net Income, 1 Yr. Growth %	40.35	21.95	43.39	13.93	24.61
Diluted EPS Before Extra, 1 Yr. Growth %	28.77	0.87	36.44	4.31	15.25
Accounts Receivable, 1 Yr. Growth %	47.03	22.02	38.62	26.28	170.82
Inventory, 1 Yr. Growth %	35.12	4.35	19.06	18.41	33.97
Net Property, Plant and Equip., 1 Yr. Growth %	-1.77	6.87	2.26	10.73	20.44
Total Assets, 1 Yr. Growth %	56.19	33.21	-19.72	52.29	11.82
Tangible Book Value, 1 Yr. Growth %	-11.29	-132.65	529.04	-123.75	345.76
Common Equity, 1 Yr. Growth %	48.78	-78.57	-477.4	-185.98	158.95
Cash From Operations, 1 Yr. Growth %	65.63	10.22	33.91	27.53	36.72
Capital Expenditures, 1 Yr. Growth %	16.81	35.52	34.52	64.98	48.52
Levered Free Cash Flow, 1 Yr. Growth %	67.7	10.51	92.51	8.65	27.67
Unlevered Free Cash Flow, 1 Yr. Growth %	70.05	-0.18	83.09	8.94	31.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.52	22.16	27.26	21.75	40.96
Gross Profit, 2 Yr. CAGR %	13.38	23.59	28.86	20.88	42.04
EBITDA, 2 Yr. CAGR %	26	37.21	38.24	29.21	21.18
EBITA, 2 Yr. CAGR %	26.24	35.52	37.11	28.93	21.25
EBIT, 2 Yr. CAGR %	24.93	34.26	36.18	28.26	20.87
Earnings From Cont. Operations, 2 Yr. CAGR %	30.73	27.96	31.32	37.75	30.51
Net Income, 2 Yr. CAGR %	30.73	27.96	31.32	37.75	30.51
Normalized Net Income, 2 Yr. CAGR %	27.28	30.83	32.24	27.81	19.15
Diluted EPS Before Extra, 2 Yr. CAGR %	13.54	13.97	17.32	19.3	9.65
Accounts Receivable, 2 Yr. CAGR %	12.52	33.94	30.06	32.31	84.93
Inventory, 2 Yr. CAGR %	53.84	18.74	11.46	18.74	25.95
Net Property, Plant and Equip., 2 Yr. CAGR %	-8.11	2.46	4.54	6.41	15.48
Total Assets, 2 Yr. CAGR %	29.43	44.24	3.41	10.57	30.49
Tangible Book Value, 2 Yr. CAGR %	-3.35	-46.18	43.3	22.22	2.89
Common Equity, 2 Yr. CAGR %	25.24	-43.54	-10.08	80.13	49.21
Cash From Operations, 2 Yr. CAGR %	20.39	35.11	21.49	30.68	32.05
Capital Expenditures, 2 Yr. CAGR %	-58.47	25.82	35.02	48.98	56.54
Levered Free Cash Flow, 2 Yr. CAGR %	-4.89	36.16	45.81	44.63	17.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	-3.88	30.31	35.19	41.23	19.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	167.6	21.6	22.9	24.5	35.2
Gross Profit, 3 Yr. CAGR %	169.02	19.22	24.38	24.42	36.47
EBITDA, 3 Yr. CAGR %	5.65	27.95	39.07	30.26	28.15
EBITA, 3 Yr. CAGR %	6.23	27.56	37.79	29.5	28.07
EBIT, 3 Yr. CAGR %	6.11	26.67	36.93	28.91	27.66
Earnings From Cont. Operations, 3 Yr. CAGR %	10.26	23.71	36.6	28.1	38.41
Net Income, 3 Yr. CAGR %	10.26	23.71	36.6	28.1	38.41
Normalized Net Income, 3 Yr. CAGR %	8.47	25.48	34.89	25.83	26.74
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.76	9.15	21.02	12.81	17.94
Accounts Receivable, 3 Yr. CAGR %	64.06	15.6	35.48	28.78	67.99
Inventory, 3 Yr. CAGR %	112.01	35.17	18.85	13.73	23.61
Net Property, Plant and Equip., 3 Yr. CAGR %	61.59	-3.36	2.39	6.56	10.89
Total Assets, 3 Yr. CAGR %	27.18	30.68	18.65	17.65	10.99
Tangible Book Value, 3 Yr. CAGR %	5.56	-32.69	22.13	-21.29	88.14
Common Equity, 3 Yr. CAGR %	25.38	-30.47	6.36	-11.41	103.3
Cash From Operations, 3 Yr. CAGR %	12.09	16.9	34.71	23.47	32.67
Capital Expenditures, 3 Yr. CAGR %	-17.73	-38.4	28.65	44.35	48.83
Levered Free Cash Flow, 3 Yr. CAGR %	5.28	-0.01	53.16	32.19	38.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.07	-2.66	46.29	25.8	37.79
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	98.78	21.66	29.83
Gross Profit, 5 Yr. CAGR %	10.58	-	100.41	19.88	31.16
EBITDA, 5 Yr. CAGR %	15.85	20.4	17.32	28.19	31.43
EBITA, 5 Yr. CAGR %	16.18	20.4	17.33	27.85	30.73
EBIT, 5 Yr. CAGR %	16.19	20.41	17.25	27.3	30.26
Earnings From Cont. Operations, 5 Yr. CAGR %	19.78	20.11	18.24	29.15	34.13
Net Income, 5 Yr. CAGR %	19.78	20.11	18.24	29.15	34.13
Normalized Net Income, 5 Yr. CAGR %	18.45	21.03	17.42	26.41	28.36
Diluted EPS Before Extra, 5 Yr. CAGR %	6.36	6.23	4.82	13.1	16.33
Accounts Receivable, 5 Yr. CAGR %	-	-	49.5	22.02	53.44
Inventory, 5 Yr. CAGR %	-	-	63.93	28.34	21.64
Net Property, Plant and Equip., 5 Yr. CAGR %	56.98	52.36	35.76	0.43	7.44
Total Assets, 5 Yr. CAGR %	39.2	29.09	17.08	22.23	23.25
Tangible Book Value, 5 Yr. CAGR %	9.48	-26.15	19.29	-14.55	14.04
Common Equity, 5 Yr. CAGR %	21.58	-24.61	9.77	1.75	21.78
Cash From Operations, 5 Yr. CAGR %	19.88	20.2	15.76	22.23	33.64
Capital Expenditures, 5 Yr. CAGR %	11.66	26.91	0.3	-12.3	39.16
Levered Free Cash Flow, 5 Yr. CAGR %	15.96	17.48	20.1	16.05	37.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.22	16.61	17.04	13.12	34.94